Evidence map›Paper›PMID 34202587›Full record

ReviewDiagnostics (Basel, Switzerland)2021

Comprehensive Survey of Using Machine Learning in the COVID-19 Pandemic.

Nora El-Rashidy, Samir Abdelrazik, Tamer Abuhmed, Eslam Amer, Farman Ali, Jong-Wan Hu, Shaker El-Sappagh

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nora El-RashidyMachine Learning and Information Retrieval Department, Faculty of Artificial Intelligence, Kafrelsheiksh University, Kafrelsheiksh 13518, Egypt.ORCID 0000-0001-8177-9439
Samir AbdelrazikInformation System Department, Faculty of Computer Science and Information Systems, Mansoura University, Mansoura 13518, Egypt.ORCID 0000-0002-1943-2861
Tamer AbuhmedCollege of Computing and Informatics, Sungkyunkwan University, Seoul 03063, Korea.ORCID 0000-0001-9232-4843
Eslam AmerFaculty of Computer Science, Misr International University, Cairo 11828, Egypt.
Farman AliDepartment of Software, Sejong University, Seoul 05006, Korea.ORCID 0000-0002-9420-1588
Jong-Wan HuDepartment of Civil and Environmental Engineering, Incheon National University, Incheon 22012, Korea.ORCID 0000-0001-6081-4469
Shaker El-SappaghCentro Singular de Investigación en Tecnoloxías Intelixentes (CiTIUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Funding

National Research Foundation of Korea 2020R1A4A4079299
6 · The paper itself

Abstract

Since December 2019, the global health population has faced the rapid spreading of coronavirus disease (COVID-19). With the incremental acceleration of the number of infected cases, the World Health Organization (WHO) has reported COVID-19 as an epidemic that puts a heavy burden on healthcare sectors in almost every country. The potential of artificial intelligence (AI) in this context is difficult to ignore. AI companies have been racing to develop innovative tools that contribute to arm the world against this pandemic and minimize the disruption that it may cause. The main objective of this study is to survey the decisive role of AI as a technology used to fight against the COVID-19 pandemic. Five significant applications of AI for COVID-19 were found, including (1) COVID-19 diagnosis using various data types (e.g., images, sound, and text); (2) estimation of the possible future spread of the disease based on the current confirmed cases; (3) association between COVID-19 infection and patient characteristics; (4) vaccine development and drug interaction; and (5) development of supporting applications. This study also introduces a comparison between current COVID-19 datasets. Based on the limitations of the current literature, this review highlights the open research challenges that could inspire the future application of AI in COVID-19.

Indexed as

artificial intelligenceCOVID_19deep learning

Identifiers

PMID34202587
PMCPMC8303306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.